Nolan Center
-
New Report: Understanding the Threat of Biological Weapons in a World with COVID-19
By Andrea Rezzonico The Council on Strategic Risks is today releasing Understanding the Threat of Biological Weapons in a World With COVID-19, an in-depth study of how the COVID-19 pandemic could influence the desirability and development of deliberate biological threats in the future. The report draws on an extensive survey of biological and weapons of…
-
Event: COVID-19 Response Technologies & Their Future Role in Pathogen Early Warning
By Lillian Parr Join the Council on Strategic Risks as we host COVID-19 Response Technologies & Their Future Role in Pathogen Early Warning on Wednesday, February 23 from 12:00–12:45 EST. RSVP here. This discussion will be hosted by Christine Parthemore, CEO of the Council on Strategic Risks. We are thrilled to host panelists from two…
-
RELEASE: The Council on Strategic Risks Selects Dr. Yong-Bee Lim as Deputy Director of the Janne E. Nolan Center for Strategic Weapons
February 14, 2022 – Today the Council on Strategic Risks (CSR) announced it has selected Dr. Yong-Bee Lim as its new Deputy Director of the Janne E. Nolan Center for Strategic Weapons (The Nolan Center). Dr. Lim had previously served as a Fellow at the Nolan Center. Prior to joining CSR, he worked in different…
-
Event: How are Biological Threats Evolving?
By Lillian Parr On Friday, February 18 from 12:30pm – 2:00pm EST, join the Council on Strategic Risks as we host How are Biological Threats Evolving in a World with COVID-19, a webinar featuring a keynote address from Assistant Secretary of Defense (ASD) Deborah Rosenblum and discussion from a panel of experts. RSVP here. This…
-
We’re Hiring! Full-Time Position in the Janne E. Nolan Center on Strategic Weapons
The Council on Strategic Risks (CSR) seeks a full-time staff member to join the Janne E. Nolan Center on Strategic Weapons, an institute of CSR. The person filling this role will initially focus much of their time on CSR’s projects that address biological risks. Depending on CSR’s growth, and the skills and interests of the…
-
RELEASE: Top Experts Release Handbook for Ending Catastrophic Biological Risks
December 20, 2021, Washington, DC – In a time of daily confusion in the public discourse on the current pandemic, the Janne E. Nolan Center on Strategic Weapons, an institute of the Council on Strategic Risks (CSR), is releasing A Handbook For Ending Catastrophic Biological Risks: How The United States Can Prevent Future Pandemics and…
-
CSR Webinar: Preventing the Next Pandemic—Leveraging Today’s Tools to Address the Biological Threats of the Future
By Lillian Parr On Monday, November 15, the Council on Strategic Risks (CSR) hosted a webinar to discuss innovative technologies for addressing biological risks and how the U.S. government can most effectively invest in them. These technologies span a broad range of technological readiness and include disease forecasting tools, diagnostics, medical countermeasures, and much more.…
-
Nuclear War and Climate Change: The Urgency for Action
By Christine Parthemore I had the honor of delivering a keynote speech at a COP26 side event hosted by the International Forum for Understanding on November 1, 2021, on the subject of nuclear war and climate change. My remarks were followed by a panel of talented, cross-discipline emerging leaders. The evening was capped with a…
-
BRIEFER: Key U.S. Initiatives for Addressing Biological Threats Part 6
By Dr. Rohit Chitale, Dr. Yong-Bee Lim, and Lillian Parr Today the Nolan Center, an institute of the Council on Strategic Risks, is releasing its sixth briefer in its series Key U.S. Initiatives for Addressing Biological Threats, which focuses on the U.S. Department of Defense’s Defense Advanced Research Projects Agency (DARPA). COVID-19, the disease caused…
-
CSR Webinar—Operation Warp Speed: The Interagency and Public-Private Collaborations that Drove It
By Lillian Parr On Wednesday, October 27, the Council on Strategic Risks (CSR) hosted a webinar to discuss how the successes and challenges of Operation Warp Speed—the U.S. federal government’s effort to drive the development of COVID-19 vaccines—can be built upon in the future. This conversation on the future of rapid development, manufacturing, and delivery…